Drug Type Monoclonal antibody |
Synonyms IC 100-03 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | US | 22 Mar 2024 | |
Neurodegenerative Diseases | Preclinical | US | 18 Dec 2021 |